Aktive Positionen von Christopher Taylor
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Investor Relations Kontakt | - | - |
| Public Communications Contact | - | - |
Karriereverlauf von Christopher Taylor
Ehemalige bekannte Positionen von Christopher Taylor
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CODIAK BIOSCIENCES | Investor Relations Kontakt | 01.12.2020 | 01.06.2023 |
| Public Communications Contact | 01.12.2020 | 01.06.2023 | |
| ALAUNOS THERAPEUTICS, INC. | Investor Relations Kontakt | 01.03.2019 | - |
| Public Communications Contact | 01.03.2019 | - |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Investor Relations Contact | 3 |
| Public Communications Contact | 3 |
Sektoral
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Christopher Taylor
- Erfahrung
